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Methods: Two groups of sedentary individuals with T1D (n = 7 per group) completed 6 weeks of thrice weekly HIT or MICT. Pre-and post-training measurements were made of 24-hour interstitial glucose profiles, using continuous glucose monitors, and cardiometabolic health markers [peak oxygen consumption ( _ VO 2peak ), blood lipid profile, and aortic pulse wave velocity (aPWV)]. Capillary blood glucose (BG) concentrations were assessed before and after exercise to investigate changes in BG levels during exercise in the fed state.
Results: Six weeks of HIT or MICT increased _ VO 2peak by 14% and 15%, respectively (P , 0.001), and aPWV by 12% (P , 0.001), with no difference between groups. There was no difference in incidence or percentage of time spent in hypoglycemia after training in either group (P . 0.05). In the fed state, the mean change (6SEM) in capillary BG concentration during the HIT sessions was 20.2 6 0.5 mmol/L, and 25.5 6 0.4 mmol/L during MICT.
Conclusions: Six weeks of HIT improved _ VO 2peak and aPWV to a similar extent as MICT. That BG levels remained stable during HIT in the fed state but consistently fell during MICT suggests HIT may be the preferred training mode for some people with T1D. (J Clin Endocrinol Metab 104: 604-612, 2019) R egular exercise is recommended for people with type 1 diabetes (T1D) to maintain overall health and reduce the risk of macrovascular and microvascular complications, which are a major cause of mortality and morbidity (1, 2) . The current guidelines for people with T1D are to undertake at least 150 minutes of moderate to vigorous aerobic exercise per week, spread over at least 3 days per week, with no more than two consecutive days without activity (3) . Benefits of exercise for those with T1D include improved aerobic capacity ( _ VO 2max ), insulin sensitivity, body composition, endothelial function, and blood lipid profile (1, (4) (5) (6) . Despite the benefits, few people with T1D achieve exercise targets and many programs designed to increase physical activity have failed (7, 8) . In addition to the barriers to exercise cited by the general population, such as a perceived lack of time, work commitments, and cost (9) , people with T1D face additional barriers, including fear of hypoglycemia, loss of glycemic control, and inadequate knowledge about exercise management (10, 11) .
To overcome a perceived lack of time, high-intensity interval training (HIT) is purported as a time-efficient alternative to moderate-intensity exercise to improve numerous cardiometabolic risk factors including _ VO 2max , insulin sensitivity, and glycemic control in people without T1D (12, 13) . Furthermore, results from our laboratory show that a single bout of HIT does not increase the risk of hypoglycemia in people with T1D (14) . Whether HIT offers a safe, effective, and timeefficient training strategy to improve cardiometabolic health and reduce the risk of hypoglycemia in people with T1D has not yet been investigated, to our knowledge.
We investigated the hypothesis that 6 weeks of HIT would improve markers of cardiometabolic health, including peak oxygen consumption ( _ VO 2peak ), glycemic control, blood lipid profile, and vascular health in people with T1D. A moderate-intensity continuous training (MICT) group was used as a control. During this 6-week training period, capillary blood glucose (BG) concentrations were monitored before and after exercise sessions to provide additional information on the acute effects of HIT and MICT on BG concentration.
Methods
Fourteen previously sedentary people with T1D (n = 10 men; Table 1 ) treated with a basal-bolus insulin regimen completed 6 weeks of supervised HIT (n = 7) or MICT (n = 7) three times per week. Participants were pair-matched in each training group on the basis of sex, age, and _ VO 2peak . Exclusion criteria were duration of T1D ,6 months; insulin pump therapy; poor diabetes control (HbA1c .86 mmol/mol); frequent hypoglycemia (more than five events per week) and/or hypounawareness (determined from medical history); obesity (body mass index .30 kg/m 2 ); pregnancy or planning pregnancy; uncontrolled hypertension (blood pressure .180/100 mm Hg); angina; autonomic neuropathy; taking any medication that affects heart rate; major surgery planned within 6 weeks of the study; or severe nonproliferative and unstable proliferative retinopathy. Testing took place in the laboratory of the School of Sport and Exercise Sciences at Liverpool John Moores University. The study was approved by the Black Country National Health Service Research Ethics Committee (West Midlands, United Kingdom), and all participants gave written informed consent to a protocol conforming to the Declaration of Helsinki.
Pretraining assessments
Participants first performed an incremental exercise test to exhaustion on an electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, Netherlands) to determine maximal aerobic power output (W max ) and _ VO 2peak using an online gas collection system (MOXUS modular metabolic system; AEI Technologies, Pittsburgh, PA). The test consisted of 3-minute stages, starting at 60 W and increasing the workload by 35 W at each stage until subjects could not maintain a cadence of .50 rpm, at which point the test was terminated. _ VO 2peak was taken as the highest value achieved over a 15-second recording period. Participants also completed a food diary over a minimum of 3 days to calculate habitual caloric and macronutrient intake.
Three to 7 days after the incremental exercise test, participants attended the laboratory after an overnight fast (.10 hours) for a second pretraining assessment session. After a 15-minute rest, brachial artery blood pressure measurements, taken with the participant supine, were made in triplicate using an automated sphygmomanometer (Dinamap Pro 300®; GE Medical Systems, Tampa, FL). Aortic pulse wave velocity (aPWV) measurements were made using a semiautomated device and software (SphygmoCor; AtCor Medical, Sydney, Australia), as previously described by Cocks et al. (15) . A fasting blood sample was used to determine fasting plasma cholesterol and triglyceride concentrations, using a semiautomatic spectrophotometer (Randox RX Daytona, County Antrim, United Kingdom). A Dexcom G4 Platinum continuous glucose monitor system (CGMS; Dexcom, San Diego, CA) probe was inserted subcutaneously into the abdomen. A habitual, free-living, 24-hour glucose profile was analyzed at least 24 hours after the CGMS was inserted. Participants were trained to use the CGMS and instructed to calibrate the device a minimum of four times daily using capillary blood tests. Participants were provided with a standardized diet of three meals (breakfast, lunch, and dinner) during the CGMS period (50% carbohydrate; 30% fat; 20% protein) in accordance with their habitual calorie intake. Participants were instructed to consume these meals at predetermined times throughout the day. No additional snacks were permitted and participants only consumed the food provided by the research team during this period, unless they needed to prevent hypoglycemia (BG concentration ,3.0 mmol/L) (16) . A food diary was completed to confirm they had consumed the prescribed food at the correct times. Participants were instructed to avoid alcohol and caffeine, as well as exercise throughout the CGMS period.
Exercise training
Training started ;72 hours after completion of the preexperimental procedures. Participants trained three times per week for 6 weeks under researcher supervision on a Lode Corival cycle ergometer (Corival Lode BV, Groningen, Netherlands). After a 3-minute low-intensity warm-up, the HIT group performed repeated 1-minute bouts of high-intensity cycling at a workload equivalent to 100% _ VO 2peak interspersed with 1 minute of recovery at 50 W, whereas the MICT group performed continuous moderate-intensity cycling at a workload equivalent to 65% _ VO 2peak . The number of intervals in the HIT group increased from six in weeks 1 and 2, to eight in weeks 3 and 4, to 10 in weeks 5 and 6. The duration of the sessions in the MICT group were 30 minutes in weeks 1 and 2, 40 minutes in weeks 3 and 4, and 50 minutes in weeks 5 and 6.
Acute change in BG levels with exercise
Participants were able to attend their training session between 7 AM and 5 PM Monday to Friday. The amount and type of food were not controlled, but we asked participants not to fast before exercising and not to exercise within 30 minutes of a meal, with the aim being to study the effects of HIT and MICT under real-world conditions. Therefore, these training sessions are defined as being in the "fed" state in this investigation. In line with advice used in other studies (17) , and in keeping with internationally agreed-upon advice (18) , if patients were doing MICT within 2 hours of a meal, they were asked to reduce their fast-acting insulin dose at that meal by 50%. No adjustments were made if doing a HIT session. Before starting and after completing each training session during the 6-week training period, each participant's BG concentrations were required to be between 7 and 14 mmol/L. If BG concentrations were outside this range, corrective measures were taken: Glucose was ingested if BG concentration was ,7 mmol/L, and a light walk or insulin bolus was advised if glucose concentration was .14 mmol/L, and blood ketone levels were checked. In addition, when participants first started exercising, they were asked to check their glucose at 2 AM and to reduce their night-time background insulin dose by 10%. Reduction of insulin at night could be continued if the participant found that their glucose level was going low overnight on the day of exercise. All participants were asked to measure their BG levels before and after an exercise session. In addition, participants in the MICT arm were advised to check their BG level partway through the exercise and to consume carbohydrate as necessary to prevent hypoglycemia. Over the 6 weeks of training, we gathered preand postexercise BG concentrations from a total of 108 MICT training sessions (86%) and 87 HIT sessions (69%).
Post-training assessments
Approximately 72 hours after the final training session, participants attended the laboratory on two occasions (separated by 72 hours) to complete a series of post-training assessments. These assessments were identical in all respects to those undertaken before training (pretraining assessments).
Statistical analyses
The primary outcome variable to measure a significant training benefit was _ VO 2peak . Findings from previous research in our group (17, 19) suggested a SD of 2.7 to 3.2 to detect a change in _ VO 2peak of 3.5 mL/kg/min, which is a clinically significant increase in _ VO 2peak (19) . A power calculation suggested that seven to nine participants were required in each group for a within-group difference to be detected with a paired t test with 80% power at a significance level of 0.05.
CGMS data were downloaded from the device using Dexcom Studio software (version 12.0.4.6) and analyzed in accordance with the International Consensus on Use of Continuous Glucose Monitoring (20) . Glycemic thresholds were defined as follows: target range, 3.9 to 10 mmol/L; level 1 hypoglycemia, #3.9 mmol/L; level 2 hypoglycemia, # 2.9 mmol/L; and hyperglycemia, $10 mmol/L). The 24-hour period was defined as 8 AM to 8 AM and the nocturnal period was defined as 12 AM to 6 AM. All variables were analyzed using a two-way mixed ANOVA, with the between factor "group" (i.e., HIT vs MICT) and repeated factor "training status" (i.e., pretraining vs post-training), followed by Bonferroni post hoc corrections. A two-way mixed ANOVA, with the between factor "group" and the repeated factor "time point" (i.e., pretraining vs post training), was used to assess whether there was an acute change in BG concentration after HIT and MICT in the fed state over the 6 weeks of training. The CGMS did not work on one participant in the MICT group. aPWV readings were obtained from five participants in the HIT group and six in the MICT group.All analyses were performed using IBM SPSS Statistics for Windows, version 22.0 (IBM, Armonk, NY). Data are presented as mean 6 SEM and significance was set at P # 0.05.
Results
By design, there were no differences in age (P = 0.877), _ VO 2peak (P = 0.371), or duration of T1D (P = 0.291) between the training groups at baseline. Body mass index, however, was significantly higher in the HIT group compared with the MICT group (P = 0.038). Pre and post-training variables are presented in Table 1 . Training increased _ VO 2peak (HIT, 14%; MICT, 15%; P , 0.001) and W max (HIT, 13%; MICT, 14%; P , 0.001), with no difference between groups (Fig. 1) . Six weeks of training also improved aPWV (P = 0.001) and there was no difference between groups. Systolic, diastolic, and mean arterial blood pressures did not improve after training (P = 0.219, 0.476, and 0.268, respectively). There was no change in plasma cholesterol or triglyceride concentrations with training (P = 0.881 and 0.652, respectively).
Glycemic control
Glucose data from the CGMS obtained over 24 hours pre-and post-training are listed in Table 2 . There was no difference in the time spent in level 1 hypoglycemia (glucose concentration #3.9 mmol/L) over the 24 hours (P = 0.727) or the nocturnal (P = 0.289) periods, with training. Similarly, there was no difference in time spent in level 2 hypoglycemia (glucose concentration #2.9 mmol/L) with training over the 24-hour (P = 0.442) or nocturnal (P = 0.397) periods. Neither were there differences in the time spent in target range over the 24-hour (P = 0.412) or nocturnal (P . 0.382) periods, or in hyperglycemia over the respective time periods (P = 0.540 and 0.118). However, there was an interaction effect for the time spent in target range (P = 0.034) and time in hyperglycemia over the nocturnal period (P = 0.039).
Post hoc analysis revealed that the HIT group spent significantly less time in target glycemia during the nocturnal period (P = 0.038), which was due to a greater time spent in hyperglycemia over the nocturnal period (P = 0.016). The incidence of level 1 hypoglycemia over the 24-hour (P = 0.675) and nocturnal (P = 0.363) periods was no different before and after HIT or MICT. There were no differences in the incidence of level 2 hypoglycemia over the respective time periods (P = 0.174 and 0.549) after 6 weeks of HIT or MICT.
Acute change in BG levels during training sessions
When quantifying the change in BG concentration during exercise training sessions undertaken in the fed state over the 6-week intervention, the mean change in BG concentration in response to HIT was 20.2 6 0.5 mmol/L (P , 0.001), whereas BG decreased by 25.5 6 0.4 mmol/L in response to MICT (P = 0.626; Fig. 2 ).
Discussion
In this study, we demonstrated that 6 weeks of HIT improved _ VO 2peak and aPWV in people with T1D to a similar magnitude as MICT. We also observed that BG concentration remained stable during the HIT sessions performed in the fed state throughout the training program, but there was a consistently large drop in BG concentration during MICT throughout the training program, with participants at risk for hypoglycemia.
The CGMS data revealed that 24-hour glucose levels were not affected by either form of training. However, there was a decrease overnight in the time spent in target range in the HIT group, due to an increase in time spent in hyperglycemia, whereas there were no changes in glycemic control in the MICT group. That HIT is a timeefficient training mode that improved _ VO 2peak and aPWV to a similar extent as MICT but did not cause a fall in glucose levels during exercise as was observed during MICT suggests HIT may be a more practical exercise strategy for some patients with T1D. However, the increase in nocturnal hyperglycemia after HIT is of concern and suggests that people with T1D may have to reduce their carbohydrate intake before and/or after HIT sessions or make changes to their night-time background insulin dose to prevent high glucose levels overnight. https://academic.oup.com/jcem_ VO 2max improved to a similar extent after 6 weeks of HIT and MICT, despite the weekly time commitment being 54 to 90 minutes less for HIT than for MICT. The 14% increase in _ VO 2peak observed in our investigation after HIT (a mean increase of 4.9 mL/kg/min) is high in comparison with the changes of 7% to 10% reported in populations without T1D in other studies using similar protocols (21) . The only other study, to our knowledge, to examine the effect of sprint interval training in people with T1D (repeated 30-second maximal cycling bouts interspersed with 3 to 4 minutes of rest three times a week for 7 weeks) reported a 7% increase in _ VO 2peak (22) . This has clinical importance given that _ VO 2max is reported to be the strongest prognostic marker of cardiovascular Glucose target range was defined as 3.9 to 10 mmol/L. There were no differences in any of the variables with training (P . 0.05).
Abbreviations: CV, coefficient of variation; Post, after training; Pre, before training. a Defined as 8 AM to 8 AM.
b Defined as #3.9 mmol/L.
c Defined as #2.9 mmol/L (severe). mortality (19) and improvements in _ VO 2max with exercise training are associated with a reduction in all-cause mortality risk (23) . In fact, Myers (19) reported an 8% to 17% reduction in all-cause mortality for each 1 metabolic equivalent (;3.5 mL/kg/min) increase in _ VO 2max . Although these correlations have not been specifically confirmed in people with T1D, it is likely that the HIT program we used induces clinically meaningful benefits to this population, which is especially important because they are at increased risk of cardiovascular disease compared with a nondiabetic population (1, 2) .
In the current study, there was a 12% reduction in aPWV after both training modes, which is greater than has previously been reported in other training studies in populations without T1D (24, 25) . To our knowledge, this is the first study to investigate changes in arterial stiffness after HIT and MICT in people with T1D. The reduction in aPWV is of clinical relevance because increased arterial stiffness is associated with negative cardiovascular outcomes (26) .
Neither training mode improved glycemic control, according to the CGMS data, measured as time spent in target range (euglycemia) or hypoglycemia or the incidences of hypoglycemia. Previous studies using HbA1c and daily insulin dose as a marker of glycemic control also did not show overall improvements in glycemic control with exercise training (22, 27, 28) , although studies reporting positive effects of training on glycemic control do exist (29) . There was a reduction in the time spent in euglycemia overnight in the HIT group, which was due to an increase in the time spent in hyperglycemia. Although increasing the proportion of time spent in hyperglycemia during the nocturnal period is not desirable, it did reduce the risk of developing hypoglycemia, which may mean that HIT is a preferable form of training for those concerned about hypoglycemia during exercise. The increased time spent in hyperglycemia overnight with HIT is concerning, given that this would increase the risk of long-term complications, and so needs to be explored further.
There are three potential reasons for this rise in glycemia with HIT. First, the increase could be due to an increase in adrenaline and noradrenaline postexercise. Although this may explain the higher glucose levels just after exercise, this is unlikely to explain the higher nocturnal glycemia, because levels of these hormones fall rapidly after cessation of exercise. This is further supported by another study (30) performed in our laboratory in which CGMS data were used to show that an acute bout of HIT did not increase glucose levels postexercise or in the overnight period. A second reason may be that participants consumed too much carbohydrate in the HIT condition, because the total workload of HIT is less than MICT, meaning that less glucose is removed from the blood to replenish muscle and liver glycogen stores. Third, there may have been inadequate background insulin overnight. At the start of training, participants were asked to reduce their overnight background insulin dose by 10%. Thereafter, whether they did this depended on their BG concentration before they went to bed and on the previous days after training, and how concerned they were about their BG levels becoming low overnight. It may be that participants reduced their overnight background insulin dose when this was not required. Unfortunately, we did not record participants' insulin doses, so we do not know if this happened. Although the use of CGMS in our investigation allowed a detailed analysis of glycemic control, we acknowledge that exercise training programs of longer duration and with larger sample sizes are needed to assess the effects of exercise training on long-term glycemic control. Furthermore, the current guidelines suggest that a minimum of 14 consecutive days should be recorded when analyzing CGMS data (20) . Unfortunately, these guidelines were published after our data collection was completed; the guidelines will be used in future studies.
Before the training sessions, we recorded participants' BG concentrations for safety reasons to prevent participants from exercising when glucose concentrations were too high or low, based on the Exercising for Type 1 Diabetes (EXTOD) guidelines (31) . BG levels also were recorded after the sessions so participants did not leave the laboratory while they were potentially at increased risk of hypoglycemia. This meant we collected pre-and postexercise BG readings from up to 18 training sessions for each participant over the course of 6 weeks of HIT or MICT. We collected pre-and postexercise BG concentrations from a total of 108 MICT training sessions (86%) and 87 HIT sessions (69%). During the HIT sessions, glucose levels remained stable throughout the training program, whereas during MICT sessions, there was a consistently large fall in glucose levels. This was a consistent observation across all participants undertaking MICT (Fig. 2B) . Readings from at least nine sessions were available for every participant and the clear differences between the groups and the low SD values for the changes in BG levels suggest the results were not affected by the different number of readings per group. The changes we report in BG concentration during the exercise are striking. Furthermore, they are supported by the findings of García-García et al. (32) , who conducted a systematic review and meta-analysis in which they aggregated results from 10 studies to estimate rate of change of glucose concentration during and after different types of exercise in people with T1D. Their results showed a rapid decline in glycemia during continuous exercise (24. 43 mmol/L/h on average), whereas the results were more variable during intermittent high-intensity exercise, depending on the protocol.
The drop in BG concentration during the MICT sessions is likely due to the effects of short-acting insulin in the circulation. In healthy individuals, BG concentration remains stable during moderate-intensity aerobic exercise because insulin secretion is suppressed progressively with exercise duration and there is a gradual increase in glucagon and adrenaline levels, resulting in increased hepatic glucose production (33, 34) . Therefore, contraction-mediated glucose uptake is matched by increased hepatic glucose production so BG concentration remains stable at ;4.0 to 6.0 mmol/L (33). However, because insulin is supplied exogenously in people with T1D, hyperinsulinemia is likely to occur because of increased blood flow and mobilization of insulin from its subcutaneous depot, particularly if the injection site is in an exercised region (33) . This results in enhanced glucose uptake due to combined contraction-mediated and insulin-stimulated GLUT4 translocation. The high insulin levels will also suppress the exercise-mediated increases in glucagon and adrenaline and their ability to stimulate hepatic glucose production (35) . As a result, muscle glucose uptake during MICT will exceed hepatic glucose production, leading to the large decreases in plasma glucose concentration observed in this study (Fig. 2) .
Hyperinsulinemia has also been shown to suppress adipose tissue and intramuscular triglyceride lipolysis in healthy individuals (36) , which will reduce the contribution of lipids to the fuel mixture oxidized during exercise. The combination of insulin and exercise-mediated glucose disposal coupled with decreased hepatic glucose production, lipolysis, and lipid oxidation, increases the risk of hypoglycemia during MICT. On the other hand, the stable BG concentrations after HIT are likely due to greater plasma catecholamine (particularly noradrenaline) concentrations, which lead to an increase in hepatic glucose production, thus offsetting the effects of hyperinsulinemia (37) . Addition of a sprint to a bout of moderate-intensity exercise in individuals with T1D opposed the fall in glycemia during exercise and this was associated with a rise in catecholamine levels (38) . It may be speculated that after a bout of HIT, the greater catecholamine response compared with MICT may lead to stimulation of adipose tissue lipolysis and increase oxidation of the released fatty acids in the muscle during recovery (39) .
Another important observation, although not quantitatively reported here, was the number of training sessions in which participants had to prevent or treat an episode of hypoglycemia by consuming fast-acting carbohydrate. During the MICT sessions, participants were advised to stop exercising at least once to check their BG concentration in accordance with the EXTOD guidelines (31), correct accordingly with glucose if necessary, and then wait for their BG to stabilize before recommencing the training. Many of the participants in the MICT condition found this frustrating and it would often mean that the already time-consuming 50-minute cycling sessions were even longer while BG was checked. The large drop in BG concentration that occurred during the MICT sessions highlights why the guidelines recommend carbohydrate should be taken when doing .30 minutes of moderate-intensity exercise (40) . Therefore, these findings provide evidence that HIT may be a more practical form of exercise for people with T1D who regularly experience problems with hypoglycemia during exercise.
The main strengths of this investigation were the strict dietary standardization under free-living conditions during the CGMS period pre and post-training, and the monitoring of acute changes in BG concentrations during exercise throughout the intervention. We also acknowledge that there are some limitations. The sample size of the study was small; however, the clear, significant increases in _ VO 2peak suggest the study was powered enough to allow us to conclude that HIT is effective at improving _ VO 2peak in people with T1D. Second, we did not record insulin dose before and after the training intervention. This would be useful to determine whether there is a change in insulin sensitivity, because reduced insulin dose is associated with decreased risk of cardiovascular complications in people with T1D (41, 42) .
In summary, we demonstrated in this study that 6 weeks of HIT led to comparable improvements in _ VO 2peak and arterial stiffness to those occurring with MICT. HIT may be the preferred exercise approach, however, because BG concentration remains stable during HIT but falls substantially during MICT. Therefore, we recommend that HIT in the fed state is a safe, effective, flexible, and time-efficient form of exercise for people with T1D. 
